Clinical diagnostic laboratory tests
This article was originally published in The Gray Sheet
Negotiated rulemaking committee is expected to meet for the final time Aug. 30-31 in Washington, D.C. to allow members to consider comments on HCFA's proposed rule embodying national coverage decisions for 23 tests or groups of tests (1"The Gray Sheet" Feb. 1, p. 3). A Federal Register notice announcing the meeting is expected to publish in the next few weeks
You may also be interested in...
After nine meetings, the Negotiated Rulemaking Committee on Clinical Diagnostic Laboratory Tests has agreed in principle on 23 national Medicare coverage and administrative policies. However, members also decided during their contentious Jan. 25-27 gathering in Washington, D.C. to meet one last time July 12-13 to approve and sign their final product, a proposed rule.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.